Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Shire Nabs Advanced BioHealing Before It Can Test the Public Waters

This article was originally published in The Pink Sheet Daily

Executive Summary

Diversifying further, the specialty outfit will spend $750 million in cash for the regenerative medicine firm and its marketed wound-healing cell therapy product.
Advertisement

Related Content

Radius Raises $91 Million, Moves Toward Public Listing
Radius Takes $91MM To Support Osteoporosis Drug, Moves Toward Public Listing
Radius Takes $91MM To Support Osteoporosis Drug, Moves Toward Public Listing
Advanced BioHealing To Bring Regeneration To Shire
Advanced BioHealing To Bring Regeneration To Shire
Shire Emphasizes The GI Space In Its Bid For Movetis
The Rebirth of Dermagraft
The Rebirth of Dermagraft
Shire/TKT: The Price of Diversification
Shire/TKT: The Price of Diversification

Topics

Advertisement
UsernamePublicRestriction

Register

PS072249

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel